Essayer OR - Gratuit
Spy series focuses on the wrong lead
Mint Mumbai
|August 16, 2025
Gaurav Shukla's spy series 'Saare Jahan Se Accha' can't add anything new to the saturated espionage genre
Saare Jahan Se Accha spends most of its time listing differences between India and Pakistan. But Netflix's new spy series can't help draw attention to a common heritage: language. Characters switch naturally between Hindi, Urdu, Punjabi and English, as so many did in undivided Punjab. The Punjabi in particular—spoken by Pakistani and Indian characters—is mellifluous, flowing off the tongues of the actors, not the same intonations you'd hear in a modern Hindi film. It reminded me of Song of Lahore (2015), Sharmeen Obaid-Chinoy's musical documentary, with the Punjabi session players hitting the consonants in trumpeter Wynton Marsalis' name: "Vin-ttun".
The show, created by Gaurav Shukla, opens with conspiracy theory (the CIA blowing up a plane with Indian nuclear physicist Homi Bhabha on board) and boilerplate spy drama truths (we operate in the shadows, our families don't know what we do). Both are delivered in a flat voiceover by Pratik Gandhi, who plays intelligence agent Vishnu Shankar. After the formation of RAW in 1968, its head, R.N. Kao (Rajat Kapoor), sends Vishnu on a top-secret mission: relocate to Islamabad and sabotage Pakistan's nuclear weapons programme.
Cette histoire est tirée de l'édition August 16, 2025 de Mint Mumbai.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint Mumbai
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

